Challenges in IBD Research 2024: Novel Technologies

Shalini Prasad, Raymond K. Cross, Mary Beth Monroe, Michael T. Dolinger, Rachel Motte, Sungmo Hong, Ryan W. Stidham, Narendra Kumar, Deborah Levine, Anthony Larijani, Ashley Simone, Karen A. Chachu, Russell Wyborski, Caren A. Heller, Alan C. Moss, Nicole M.J. Schwerbrock, Florin M. Selaru

Research output: Contribution to journalArticlepeer-review

Abstract

Novel technology is one of the five focus areas of the Challenges in Inflammatory Bowel Disease (IBD) Research 2024 document. Building off the Challenges in IBD Research 2019 document, the Foundation aims to provide a comprehensive overview of current gaps in IBD research and deliver actionable approaches to address them with a focus on how these gaps can lead to advancements in interception, remission, and restoration for these diseases. The document is the result of a multidisciplinary collaboration from scientists, clinicians, patients, and funders and represents a valuable resource for patient-centric research prioritization. Specifically, the Novel Technologies section focuses on addressing key research gaps to enable interception and improve remission rates in IBD. This includes testing predictions of disease onset and progression, developing novel technologies tailored to specific phenotypes, and facilitating collaborative translation of science into diagnostics, devices, and therapeutics. Proposed priority actions outlined in the document include real-Time measurement of biological changes preceding disease onset, more effective quantification of fibrosis, exploration of technologies for local treatment of fistulas, and the development of drug delivery platforms for precise, location-restricted therapies. Additionally, there is a strong emphasis on fostering collaboration between various stakeholders to accelerate progress in IBD research and treatment. Addressing these research gaps necessitates the exploration and implementation of bio-engineered novel technologies spanning a spectrum from materials to systems. By harnessing innovative ideas and technologies, there's a collective effort to enhance patient care and outcomes for individuals affected by IBD.

Original languageEnglish (US)
Pages (from-to)S30-S38
JournalInflammatory Bowel Diseases
Volume30
Issue numberSupplement_2
DOIs
StatePublished - May 1 2024

Keywords

  • bioengineering
  • Crohn's disease
  • fibrosis
  • real-Time measurement
  • targeting inflammation
  • ulcerative colitis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Gastroenterology

Fingerprint

Dive into the research topics of 'Challenges in IBD Research 2024: Novel Technologies'. Together they form a unique fingerprint.

Cite this